94 related articles for article (PubMed ID: 11972534)
21. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
[TBL] [Abstract][Full Text] [Related]
23. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation.
Scholl S; Sayer HG; Mügge LO; Kasper C; Pietraszczyk M; Kliche KO; Clement JH; Höffken K
J Cancer Res Clin Oncol; 2004 Dec; 130(12):704-10. PubMed ID: 15365821
[TBL] [Abstract][Full Text] [Related]
24. Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation.
Calabrese E; Zorzi F; Visconti E; De Angelis G; Cerretti R; Del Vecchio Blanco G; Picardi A; Cudillo L; Postorino M; Franceschini L; Biancone L; Arcese W; Pallone F
Dig Liver Dis; 2013 Nov; 45(11):899-904. PubMed ID: 23680035
[TBL] [Abstract][Full Text] [Related]
25. Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation.
Liu QF; Luo XD; Ning J; Xu D; Fan ZP; Sun J; Zhang Y; Xu B; Wei YQ
Hematology; 2009 Apr; 14(2):63-72. PubMed ID: 19298716
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
27. High alpha-1 antitrypsin clearance predicts severity of gut graft-versus-host disease (GVHD) in children.
Hagen LE; Schechter T; Luk Y; Brodovitch A; Gassas A; Doyle JJ
Pediatr Transplant; 2011 Sep; 15(6):659-63. PubMed ID: 21797957
[TBL] [Abstract][Full Text] [Related]
28. Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).
Bacigalupo A; Oneto R; Bruno B; Lamparelli T; Gualandi F; Bregante S; Raiola AM; Di Grazia C; Dominietto A; Lombardi A; Frassoni F; Van Lint MT
Bone Marrow Transplant; 2001 Dec; 28(11):1041-5. PubMed ID: 11781614
[TBL] [Abstract][Full Text] [Related]
29. Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
Doehn JM; Winkler A; Kuzmina Z; Hladik A; Greinix H; Knapp S; Robak O
Exp Hematol; 2016 Oct; 44(10):917-23. PubMed ID: 27403536
[TBL] [Abstract][Full Text] [Related]
30. Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation.
Inbal A; Muszbek L; Lubetsky A; Katona E; Levi I; Kárpáti L; Nagler A
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):249-53. PubMed ID: 15060422
[TBL] [Abstract][Full Text] [Related]
31. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR
Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364
[TBL] [Abstract][Full Text] [Related]
32. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.
Martino R; Caballero MD; Canals C; Simón JA; Solano C; Urbano-Ispízua A; Bargay J; Rayón C; Léon A; Sarrá J; Odriozola J; Conde JG; Sierra J; San Miguel J; ;
Br J Haematol; 2001 Dec; 115(3):653-9. PubMed ID: 11736950
[TBL] [Abstract][Full Text] [Related]
34. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
35. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
[TBL] [Abstract][Full Text] [Related]
36. Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease.
Lunn RA; Sumar N; Bansal AS; Treleaven J
Hematology; 2005 Apr; 10(2):107-14. PubMed ID: 16019456
[TBL] [Abstract][Full Text] [Related]
37. Complications Following Stem Cell Therapy in Inflammatory Bowel Disease.
Wei H; Liu X; Ouyang C; Zhang J; Chen S; Lu F; Chen L
Curr Stem Cell Res Ther; 2017; 12(6):471-475. PubMed ID: 28302045
[TBL] [Abstract][Full Text] [Related]
38. A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.
Khandelwal P; Emoto C; Fukuda T; Vinks AA; Neumeier L; Dandoy CE; El-Bietar J; Chandra S; Davies SM; Bleesing JJ; Jordan MB; Mehta PA; Jodele S; Grimley MS; Kumar A; Myers KC; Marsh RA
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2220-2225. PubMed ID: 27664325
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Norlin AC; Sairafi D; Mattsson J; Ljungman P; Ringdén O; Remberger M
Bone Marrow Transplant; 2008 Feb; 41(3):267-73. PubMed ID: 17994123
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.
Yeh AC; Brunner AM; Spitzer TR; Chen YB; Coughlin E; McAfee S; Ballen K; Attar E; Caron M; Preffer FI; Yeap BY; Dey BR
Biol Blood Marrow Transplant; 2014 May; 20(5):730-4. PubMed ID: 24530972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
